Abstract
BackgroundResistance to immune checkpoint inhibition (ICI) in patients with triple-negative breast cancer (TNBC) remains a common problem, with the underlying mechanisms not well understood. Tumor antigens bound to major histocompatibility...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
